Effect of LY3314814 on the Pharmacokinetics of Warfarin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 02 Jun 2017
At a glance
- Drugs Lanabecestat (Primary) ; Warfarin
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 17 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Nov 2015 Planned End Date changed from 1 Nov 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.